
Ask a doctor about a prescription for MODAFINIL VIATRIS 100 mg TABLETS
Patient Information Leaflet
Modafinil Viatris 100mg Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
The active substance in the tablets is modafinil. Modafinil can be used in adults to help them stay awake. This is for conditions such as narcolepsy, which causes excessive daytime sleepiness and a tendency to fall asleep suddenly in inappropriate situations (sleep attacks).
Modafinil may improve narcolepsy and reduce the chance of sleep attacks, although there may be other ways to improve your condition and your doctor will inform you of these.
Do not take Modafinil Viatris:
Warnings and precautions
Consult your doctor or pharmacist before starting Modafinil Viatris:
Other aspects to discuss with your doctor or pharmacist
During treatment
Consult your doctor or pharmacist:
These may be symptoms of a potentially life-threatening multi-organ hypersensitivity reaction.
Children and adolescents
Children under 18 years of age should not take this medicine.
Other medicines and Modafinil Viatris
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription. Modafinil Viatris and other medicines may affect each other, and your doctor may need to adjust the doses you are taking.
It is especially important if you are taking any of the following medicines with Modafinil Viatris:
Pregnancy and breastfeeding
Do not take this medicine if you are pregnant or breastfeeding.
Modafinil is suspected to cause birth defects if taken during pregnancy.
Consult your doctor about suitable contraceptive methods for you while being treated with modafinil (and for two months after stopping) or if you have any other questions.
Do not take this medicine if you are breastfeeding, as it may pass into breast milk.
Driving and using machines
Modafinil Viatris may cause blurred vision or dizziness in 1 in 10 patients.
If you notice any of these effects or notice that you still feel sleepy while taking this medicine, avoid driving vehicles or using machines.
Modafinil Viatris contains lactose.
If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.
Modafinil Viatris contains sodium.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet, which is essentially "sodium-free".
Take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist. The tablets should be swallowed whole with a little water.
Adults
The recommended dose is 200 mg per day. It can be taken once a day (in the morning) or divided into two doses per day (100 mg in the morning and 100 mg at noon). In some cases, your doctor may decide to increase your daily dose up to 400 mg.
Elderly patients (over 65 years of age)
The recommended dose is 100 mg per day.
Your doctor will only increase your daily dose (up to a maximum of 400 mg per day) if you do not have liver or kidney problems.
Adults with severe liver problems
The recommended dose is 100 mg per day.
Your doctor will periodically review your treatment to ensure it is suitable for you.
The tablets should be swallowed whole with a little water.
If you take more Modafinil Viatris than you should
If you have taken too many tablets, you may feel unwell, anxious, disoriented, confused, agitated, anxious, or excited. You may also experience difficulty sleeping, diarrhea, hallucinations (hearing, seeing, or feeling things that are not real), chest pain, a change in your heart rate, or an increase in your blood pressure. Contact the emergency department of your nearest hospital or consult your doctor or pharmacist immediately.
Bring this leaflet and any remaining tablets with you
If you forget to take Modafinil Viatris
If you forget to take your medicine, take the next dose at the usual time. Do not take a double dose to make up for forgotten doses.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking this medicine and inform your doctor immediately if:
Other side effects include the following:
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children
Do not take this medicine after the expiry date which is stated on the outer packaging and blister after EXP. The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Modafinil Viatris
The active substance is modafinil.
Each Modafinil Viatris 100 mg tablet contains 100 mg of modafinil
The other ingredients are: lactose (see section 2 "Modafinil Viatris contains lactose"), sodium croscarmellose, povidone, and magnesium stearate.
Appearance of Modafinil Viatris and pack contents
Modafinil Viatris 100 mg tablets
White or almost white, capsule-shaped tablets, approximately 12.6 mm x 5.5 mm, and marked with a "41" on one side and a "J" on the other. Available in packs of aluminum/PVC-PVdC blister packs of 30, 60, or 90 tablets and plastic bottles of 30 and 100 tablets. The bottles contain a desiccant; do not ingest the desiccant.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Manufacturer
McDermott Laboratories Limited t/a Gerard Laboratories t/a Mylan Dublin
Unit 35/36 Baldoyle Industrial Estate,
Grange Road, Dublin 13
Ireland
or
Mylan Hungary Kft.
Mylan utca 1.
Komárom, H-2900
Hungary
You can request more information about this medicine from the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
This medicine is authorized in the Member States of the European Economic Area under the following names:
United Kingdom | Modafinil 100 mg Tablets |
Spain | Modafinilo Viatris 100 mg tablets EFG |
France | Modafinil Mylan |
Sweden | Myldamo |
Denmark | Myldamo |
Iceland | Myldamo |
Revision date of this leaflet:September 2020
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of MODAFINIL VIATRIS 100 mg TABLETS in December, 2025 is around 41.95 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for MODAFINIL VIATRIS 100 mg TABLETS – subject to medical assessment and local rules.